Alpheus Medical Secures $52M for Sonodynamic Therapy in Glioblastoma Treatment
Summary
Alpheus Medical successfully closes Series B financing round to advance sonodynamic therapy (SDT) for newly diagnosed glioblastoma (GBM) patients, aiming to establish a new standard of care for brain tumors.
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected